Rating #92
Jeremy Grantham
Grantham, Mayo, Van Otterloo
Portfolio value
Stocks
Performance
1 Year
+16.12%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
Jeremy Grantham’s Portfolio: Q1 2026
Top10 stocks: 39.91% of the portfolio
Jeremy Grantham’s Trades: Q1 2026
Adds
New Buys
Sold Outs
Cuts
1.21ppt
-0.66ppt
0.99ppt
0.40ppt
-0.07ppt
-0.03ppt
0.14ppt
-0.41ppt
-0.26ppt
-0.12ppt
Company Name | Share Count Chg. (%) | Price Paid | Buy Value | Portfolio % Change | |
|---|---|---|---|---|---|
1  MA | Add +38978.71% | $526.66 | $499.46M | 1.21ppt | |
2  MSFT | Add +17.25% | $418.44 | $380.13M | -0.66ppt | |
3  NFLX | Add +12347.45% | $88.11 | $353.89M | 0.99ppt | |
4  CI | Add +32.69% | $276.68 | $177.10M | 0.40ppt | |
5  UNH | Add +18.29% | $297.81 | $145.42M | -0.07ppt | |
6  V | Add +14.59% | $321.55 | $124.30M | -0.03ppt | |
7  UBER | Add +26.55% | $76.97 | $119.11M | 0.14ppt | |
8  META | Add +5.66% | $640.86 | $105.41M | -0.41ppt | |
Add +3.43% | $314.21 | $71.95M | -0.26ppt | ||
10  AVGO | Add +6.75% | $329.05 | $69.69M | -0.12ppt |
Jeremy Grantham’s Holdings: Q1 2026
Company Name | Primary Industry | Avg. price paid  | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1 MSFT | Prepackaged Software | $259.84 | Add +17.25% | 6.18M | $2.29B | 5.85% -0.66ppt | 0.08% | 78 Quarters | Q1 2026 | |
Computer Programming & Data | $110.65 | Add +3.43% | 6.90M | $1.98B | 5.08% -0.26ppt | 0.06% | 42 Quarters | Q1 2026 | ||
3  JNJ | Pharmaceutical Pres | $145.82 | Add +2.68% | 7.28M | $1.78B | 4.55% 0.80ppt | 0.30% | 78 Quarters | Q1 2026 | |
4  AAPL | Electronic Computers | $141.46 | Add +3.44% | 6.94M | $1.76B | 4.50% -0.16ppt | 0.05% | 68 Quarters | Q1 2026 | |
5 META | Computer Programming & Data | $370.60 | Add +5.66% | 3.07M | $1.76B | 4.50% -0.41ppt | 0.12% | 33 Quarters | Q1 2026 | |
6  LRCX | Other Industry Machinery | $76.00 | Cut -26.11% | 6.90M | $1.48B | 3.77% -0.32ppt | 0.55% | 6 Quarters | Q1 2026 | |
7  AMZN | Retail-Catalog & Mail-Order | $168.75 | Cut -1.95% | 6.23M | $1.30B | 3.32% -0.43ppt | 0.06% | 31 Quarters | Q1 2026 | |
8  TMO | Other Measuring Devices | $504.88 | Add +3.74% | 2.50M | $1.23B | 3.15% -0.43ppt | 0.67% | 8 Quarters | Q1 2026 | |
9 AVGO | Semiconductors | $231.73 | Add +6.75% | 3.35M | $1.04B | 2.65% -0.12ppt | 0.07% | 21 Quarters | Q1 2026 | |
10  USB | National Banks | $43.70 | Add +3.87% | 19.11M | $994.10M | 2.54% 0.03ppt | 1.23% | 36 Quarters | Q1 2026 | |
11  TXN | Semiconductors | $150.42 | Add +3.54% | 5.06M | $982.55M | 2.51% 0.35ppt | 0.56% | 40 Quarters | Q1 2026 | |
12 V | Other Business Services | $251.85 | Add +14.59% | 3.04M | $917.64M | 2.35% -0.03ppt | 0.16% | 35 Quarters | Q1 2026 | |
13  ABT | Pharmaceutical Pres | $103.17 | Add +5.05% | 8.91M | $914.89M | 2.34% -0.38ppt | 0.51% | 70 Quarters | Q1 2026 | |
14 UNH | Medical Service Plans | $345.30 | Add +18.29% | 3.16M | $854.65M | 2.19% -0.07ppt | 0.35% | 78 Quarters | Q1 2026 | |
15  MRK | Pharmaceutical Pres | $91.90 | Add +2.09% | 7.01M | $843.69M | 2.16% 0.31ppt | 0.28% | 39 Quarters | Q1 2026 | |
16  CRM | Prepackaged Software | $238.65 | Add +7.83% | 4.43M | $826.12M | 2.11% -0.67ppt | 0.47% | 23 Quarters | Q1 2026 | |
17  ACN | Other Business Services | $227.37 | Add +7.76% | 3.90M | $773.79M | 1.98% -0.50ppt | 0.63% | 67 Quarters | Q1 2026 | |
18 CI | Medical Service Plans | $287.21 | Add +32.69% | 2.60M | $693.08M | 1.77% 0.40ppt | 0.98% | 22 Quarters | Q1 2026 | |
19  LLY | Pharmaceutical Pres | $442.57 | Add +1.43% | 749.82K | $689.66M | 1.76% -0.27ppt | 0.08% | 78 Quarters | Q1 2026 | |
20  KLAC | Optical Instruments | $555.94 | Cut -9.35% | 461.20K | $679.08M | 1.74% 0.16ppt | 0.35% | 35 Quarters | Q1 2026 |
NEWSLETTER
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersOur content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.